---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-093456"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:28:54.001248+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pyxis Oncology CFO/COO Pamela Connealy retires; Jitendra Wadhane appointed PFO

## Summary
- Pamela Connealy, CFO and COO, retired from Pyxis Oncology effective July 1, 2025; not due to any disagreement.
- Jitendra Wadhane, current SVP Finance and CAO, appointed Principal Financial Officer effective same date.
- Wadhane continues as Principal Accounting Officer; no additional compensation for PFO role.
- Connealy eligible for severance benefits per her Amended and Restated Employment Agreement (Nov 2022).

## SEC filing metadata
- accession: 0000950170-25-093456
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/0000950170-25-093456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/pyxs-20250701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-093456
- JSON: https://secwatch.observer/filing/0000950170-25-093456.json
- Plain text: https://secwatch.observer/filing/0000950170-25-093456.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.